Answer
May 31, 2024 - 09:56 AM
Rybelsus, an oral medication containing semaglutide, offers several benefits for individuals with type 2 diabetes. Primarily, it helps to improve blood sugar control by increasing insulin secretion and decreasing glucagon production. This leads to better glycemic management and reduces the risk of diabetes-related complications. Additionally, Rybelsus has been shown to promote weight loss, which is beneficial for individuals who are overweight or obese and have type 2 diabetes. The weight loss effects are attributed to appetite suppression and delayed gastric emptying. Furthermore, Rybelsus may also reduce the risk of major adverse cardiovascular events in individuals with type 2 diabetes and established cardiovascular disease.
